Editas Medicine Inc buy skatcup
Start price
05.09.21
/
80%
€58.60
Target price
05.09.22
€70.00
Performance (%)
-8.43%
End price
18.09.21
€53.66
Summary
This prediction ended on 18.09.21 with a price of €53.66. With a performance of -8.43%, the BUY prediction by skatcup finished with a loss. skatcup has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Editas Medicine Inc | 5.156% | 5.156% | -40.676% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% |
According to skatcup what are the pros and cons of Editas Medicine Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
High Investments for future growth
ROE higher than 10% per year
Capable Management
Leading role in innovation
Top 10 in its market
Very small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
Some uniques
Cons
Very low/no dividend yield expected
Dependend from some customers or products
Higher risks for its business
Comments by skatcup for this prediction
In the thread Editas Medicine Inc diskutieren
In the thread Trading Editas Medicine Inc
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.